THE BENOIT LAB
IN THE MEDIA
Yannick discusses infection-associated cancers on Radio-Canada Première
Radio-Canada Première, October 2nd, 2026
Yannick was invited to appear on La bande passante as a scientific expert to discuss the global relationship between infectious diseases and cancer. During the interview, he highlighted how certain viruses, bacteria, and parasites contribute to cancer development worldwide, as well as the important role of prevention, vaccination, and early detection in reducing the burden of infection-associated cancers.
Listen to the full interview (in French): Radio-Canada Première – La bande passante
Our work is catching attention around the globe
See the different interviews and news articles about the Benoit lab discovery of vanoxerine as a repurposed drug blocking colorectal cancer stem cell functions:
University of Ottawa lab is establishing a link between G9a activity and pluripotency in colorectal cancer stem cells
Nature Research, Cancer Community, December 16th 2020
Behind the Paper - Assistant Professor Yannick D. Benoit is commenting on the most recent article from his lab, published in Oncogene.
University of Ottawa lab takes aim at cancer stem cells
Capital Current, Ottawa, April 29th 2019
Dr. Yannick Benoît and his lab at the University of Ottawa have been awaiting the arrival of a spectral flow cytometry analyzer, cutting edge technology that could help him and his trainees contribute new information in cancer treatment research.
Meet Early Researcher Award winners Dr. Yannick Benoît and Dr. Kin Chan
Faculty of Medicine, University of Ottawa, June 1st 2018
The Early Researcher Awards aims to attract the brightest and best researchers to Ontario by providing funding to help new professors build a research team.
The Faculty of Medicine chatted with its winners for the exciting details of what they have planned for their teams.
Existing Drug Found to be Effective at Killing Cancer Stem Cells
Technology Networks, June 26th 2017
A team of researchers at McMaster University has identified a unique feature of cancer stem cells that can be exploited to kill the deadly cells thought to be the reason that cancer comes back after therapy. Understanding this feature will be useful for delivering more targeted cancer therapeutics to the right patients.
Meet the Next Generation of Canadian Researchers: Yannick Benoit
McMaster University, September 25th 2015
Recently awarded a prestigious scholarship from CRS, hear from Dr. Yannick Benoit on what this will mean for his career.